Web Analytics

3 Latest Announced Rounds

  • $20,000,000
    Series A

    5 Investors

    Technology, Information and Internet
    Jan 16th, 2026
  • $5,400,000
    Unknown

    1 Investors

    Security & Investigations
    Jan 16th, 2026
  • $30,000,000
    Series C

    3 Investors

    Semiconductor Manufacturing
    Jan 16th, 2026
$2,375.16M Raised in 64 Funding Rounds in the past 7 Days - View All

Funding Round Profile

smartbax

start up
Germany - München
  • 24/05/2023
  • Seed
  • $1,291,000

smartbax develops novel multi-targeted, antibacterial compounds with extraordinary potency against multi-drug resistant bacteria and difficult-to-treat biofilms. With the first-in-class compounds, the company targets the multi-drug resistant pathogens methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE).


Related People